SEARCH

SEARCH BY CITATION

References

  • ALBANESE, A., JENNER, P., MARSDEN, C.D. & STEPHENSON, J.D. (1988). Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci. Lett., 87, 4650.
  • ARAKI, I., KITAHARA, M., OIDA, T. & KUNO, S. (2000). Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms. J. Urol., 164, 16401643.
  • ARAKI, I. & KUNO, S. (2000). Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score. J. Neurol. Neurosurg. Psychiatry, 68, 429433.
  • ARANDA, B. & CRAMER, P. (1993). Effects of apomorphine and L-dopa on the parkinsonian bladder. Neurourol. Urodyn., 12, 203209.
  • BAIK, J.-H., PICETTI, R., SAIARDI, A., THIRIET, G., DIERICH, A., DEPAULIS, A., LE MEUR, M. & BORRELLI, E. (1995). Parkinson-like locomotor impairment in mice lacking dopamine D2 receptors. Nature, 377, 424428.
  • BERGER, Y., BLAIVAS, J.G., DELAROCHA, E.R. & SALINAS, J.M. (1987). Urodynamic findings in Parkinson's disease. J. Urol., 138, 836838.
  • BONNET, A.M., PICHON, J., VIDAILHET, M., GOUIDER-KHOUJA, N., ROBAIN, G., PERRIGOT, M. & AGID, Y. (1997). Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects. Mov. Disord., 12, 509513.
  • CALNE, D.B. (1993). Treatment of Parkinson's disease. N. Engl. J. Med., 329, 10211027.
  • DE GROAT, W.C., BOOTH, A.M. & YOSHIMURA, N. (1993). Neurophysiology of micturition and its modification in animal models of human disease. In: The Autonomic Nervous System: Nervous Control of the Urogenital System ed. Maggi, C.A., Vol. 3, pp. 227290. London: Horwood Academic Publishers.
  • DE GROAT, W.C. & YOSHIMURA, N. (2001). Pharmacology of the lower urinary tract. Annu. Rev. Pharmacol. Toxicol., 41, 691721.
  • DI CHIARA, G., MORELLI, M. & CONSOLO, S. (1994). Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci., 17, 228233.
  • HORNYKIEWICZ, O. & KISH, S.J. (1986). Biochemical pathophysiology of Parkinson's disease. Adv. Neurol., 45, 1934.
  • KONDO, M., FUJIWARA, H. & TANAKA, C. (1985). Autoradiographic evidence for dopaminergic innervation in guinea pig spinal cord. Jpn. J. Pharmacol., 38, 442444.
  • KONDO, M., FUJIWARA, H. & TANAKA, C. (1986). Dopamine release and presynaptic dopaminergic regulation in guinea pig spinal cord. Jpn. J. Pharmacol., 41, 3946.
  • KONTANI, H., INOUE, T. & SAKAI, T. (1990). Dopaminergic receptor subtypes that induce hyperactive bladder response in anesthetized rats. Jpn. J. Pharmacol., 54, 482486.
  • KUNO, S., MIZUTA, E. & YOSHIMURA, N. (1997). Differential effects of D1 and D2 agonists on neurogenic bladder in Parkinson's disease and MPTP-induced parkinsonian monkeys. Mov. Disord. Suppl., 12, 1.
  • NESTLER, E.J. (1994). Hard target: understanding dopaminergic transmission. Cell, 79, 923926.
  • PAVLAKIS, A.J., SIROKY, M.G., GOLDSTEIN, I. & KRANE, R.J. (1983). Neurourologic findings in Parkinson's disease. J. Urol., 129, 8083.
  • PRITCHARD, L.M., LOGUE, A.D., HAYES, S., WELGE, J.A., XU, M., ZHANG, J., BERGER, S.P. & RICHTAND, N.M. (2003). 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment. Neuropsychopharmacology, 28, 100107.
  • RINNE, U.K. (1985). Combined bromocriptine – levodopa therapy early in Parkinson's disease. Neurology, 35, 11961198.
  • SEKI, S., IGAWA, Y., KAIDOH, K., ISHIZUKA, O., NISHIZAWA, O. & ANDERSSON, K.E. (2001). Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats. Neurourol. Urodyn., 20, 105113.
  • STEERS, W.D., GRAY, M.L. & AMES, C.D. (2000). Effect of sublingual apomorphine on bladder function in patients with spinal cord injury. J. Urol., 163, 39A.
  • UMEMIYA, M. & RAYMOND, L.A. (1997). Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons. J. Neurophysiol., 78, 12481255.
  • WITKIN, J., GASIOR, M., ACRI, J., BEEKMAN, M., THURKAUF, A., YUAN, J., DEBOER, P., WIKSTROM, H. & DIJKSTRA, D. (1998). Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907. Eur. J. Pharmacol., 347, R1R3.
  • YOSHIMURA, N. & CHANCELLOR, M.B. (2002). Current and future pharmacological treatment for overactive bladder. J. Urol., 168, 18971913.
  • YOSHIMURA, N., MIZUTA, K., KUNO, S., SASA, M. & YOSHIDA, O. (1993). The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuropharmacology, 32, 315321.
  • YOSHIMURA, N., MIZUTA, E., YOSHIDA, O. & KUNO, S. (1998). Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys. J. Pharmacol. Exp. Ther., 286, 228233.
  • YOSHIMURA, N., SASA, M., YOSHIDA, O. & TAKAORI, S. (1990). Mediation of micturition reflex by central norepinephrine from the locus coeruleus. J. Urol., 143, 840843.
  • YOSHIMURA, N., SASA, M., YOSHIDA, O. & TAKAORI, S. (1992). Dopamine D-1 receptor-mediated inhibition of micturition reflex by central dopamine from the substantia nigra. Neurourol. Urodyn., 11, 535545.
  • YOKOYAMA, O., YOSHIYAMA, M., NAMIKI, M. & DE GROAT, W.C. (1999). Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion. Am. J. Physiol., 276, R935R942.
  • ZAPATA, A., WITKIN, J.M. & SHIPPENBERG, T.S. (2001). Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacology, 41, 351359.